Valganciclovir Hydrochloride For Solution
Product Images NDC 70010-051

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Valganciclovir Hydrochloride (NDC 70010-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovir-figure10-jpg (Valganciclovir Figure10 Jpg)

Illustration showing a hand measuring liquid medication with an oral syringe inserted into a small bottle, demonstrating the process of drawing medicine from the bottle for oral administration.*

FDA Label Image

Valganciclovir-figure11-jpg (Valganciclovir Figure11 Jpg)

An instructional illustration showing a child receiving an oral medication dose administered by a syringe held by an adult. The syringe is positioned at the child's mouth for oral delivery of the solution.*

FDA Label Image

Valganciclovir-figure12-jpg (Valganciclovir Figure12 Jpg)

An illustration showing a vial with a flip-top cap and an arrow indicating the direction to open or remove the cap, presumably for the VALGANCICLOVIR HYDROCHLORIDE oral solution vial.*

FDA Label Image

Valganciclovir-figure13-jpg (Valganciclovir Figure13 Jpg)

An instructional illustration showing a dosing syringe being rinsed under running water from a faucet. Droplets of water are depicted falling into and around the syringe, with an empty syringe shown below. This image likely demonstrates how to clean or rinse the syringe before or after use.*

FDA Label Image

Valganciclovir-figure3-jpg (Valganciclovir Figure3 Jpg)

An instructional diagram showing an oral dispenser and the bottle components for valganciclovir hydrochloride oral solution. The bottle includes a child-resistant cap, bottle adapter, and bottle. The oral dispenser consists of a plunger, barrel with measurement markings, and a tip for dispensing the solution accurately.*

FDA Label Image

Valganciclovir-figure4-jpg (Valganciclovir Figure4 Jpg)

An instructional illustration showing a hand holding a bottle labeled for oral solution, with an arrow indicating to shake well. The image demonstrates the proper way to shake the bottle before use.*

FDA Label Image

Valganciclovir-figure5-jpg (Valganciclovir Figure5 Jpg)

An instructional illustration showing steps for opening a vial or bottle cap. The image depicts an arrow pointing downward to push on the cap and a curved arrow indicating twisting motion to remove the cap from the bottle.*

FDA Label Image

Valganciclovir-figure6-jpg (Valganciclovir Figure6 Jpg)

An instructional diagram showing a syringe with a dosage indicator scale in milliliters (mL). An arrow points to the scale labeled "Dosage indicator (mL)," illustrating how to measure liquid medication accurately for oral administration.*

FDA Label Image

Valganciclovir-figure7-jpg (Valganciclovir Figure7 Jpg)

An instructional illustration showing a hand pressing down on the plunger of an oral syringe to administer a liquid medication. The diagram emphasizes the action of pushing the plunger downward to dispense the dose.*

FDA Label Image

Valganciclovir-figure8-jpg (Valganciclovir Figure8 Jpg)

An instructional illustration showing a hand holding an oral syringe above a bottle labeled with a bottle adapter opening, indicating how to connect the syringe to the bottle for solution withdrawal.*

FDA Label Image

Valganciclovir-figure9-jpg (Valganciclovir Figure9 Jpg)

An instructional illustration showing the correct method for withdrawing a liquid from a bottle into a syringe, likely for oral administration. The image depicts hands holding a bottle upside down and drawing liquid into a graduated oral syringe. This supports accurate dosing for oral liquid medications such as valganciclovir for solution.*

FDA Label Image

Valganciclovir-formula-jpg (Valganciclovir Formula Jpg)

A text panel displaying formulas for calculating Mosteller Body Surface Area (BSA) in square meters and Schwartz Creatinine Clearance in milliliters per minute per 1.73 square meters. The Mosteller BSA formula uses height and weight, while the Schwartz Creatinine Clearance formula involves constants, height, and serum creatinine levels.*

FDA Label Image

Valganciclovir-label1-jpg (Valganciclovir Label1 Jpg)

Label for Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL, human prescription drug by Granules Pharmaceuticals Inc. The label provides storage instructions, dosing preparation details, net contents of 100 mL after constitution, and cautions. The label includes an NDC 70010-051-40, expiration and lot number fields, and manufacturer information.*

FDA Label Image

Valganciclovir-label2-jpg (Valganciclovir Label2 Jpg)

Box label for Valganciclovir Hydrochloride for Oral Solution 50 mg/mL by Granules Pharmaceuticals Inc. It contains 100 mL (3.4 fl oz) of constituted oral solution with 50 mg valganciclovir free base per mL. The label includes preparation and storage instructions, pharmacist directions, and the NDC 70010-051-40.*

FDA Label Image

Valganciclovir-structure-jpg (Valganciclovir Structure Jpg)

Chemical structure of valganciclovir hydrochloride, illustrating its molecular arrangement including a purine base linked to a side chain and a hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.